77 search results for Lung
Download the Understanding Immunotherapy Side Effects Infographic (English).
. Joints Joint pain or swelling, stiffness after rest, improvement with activity Lungs Shortness
https://www.nccn.org/docs/default-source/patient-resources/immunotherapy_infographic.pdf?sfvrsn=f92249ca_36Policy Toolkit_September 2021
LungCancer MultipleMyeloma (Portuguese) Non-SmallCell LungCancer EnhancedLevel NCCN Digital
https://www.nccn.org/docs/default-source/oncology-policy-program/policy-toolkit_september-2021.pdf?sfvrsn=c54522e6_2Scientific Publications
cell lung cancer. Lung Cancer 134 (2019) 167–173. https://doi.org/10.1016/j.lungcan.2019.06.017, , Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1, therapy. JCI Insight. 2019;4(15):e130116.https://doi.org/10.1172/jci.insight.130116 Lung Cancer Auberle, SN. A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung, IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have
https://www.nccn.org/education-research/nccn-oncology-research-program/scientific-publicationsClinical Guidelines Translations
(Arabic) Non-Small Cell Lung Cancer Version 3.2023 (Arabic) Ovarian Cancer, (Chinese) Small Cell Lung Cancer Version 1.2023 (Chinese) T-Cell Lymphomas, Lung Cancer Version 3.2022 (French) Pediatric Acute Lymphoblastic Leukemia Version, (Italian) Multiple Myeloma Version 5.2022 (Italian) Non-Small Cell Lung Cancer, (Japanese) Multiple Myeloma Version 5.2022 (Japanese) Non-Small Cell Lung
https://www.nccn.org/global/what-we-do/clinical-guidelines-translationsRecently Updated Guidelines
Lung Cancer Version 11.2024 Penile Cancer Version 1.2025 Small Cell Lung Cancer, with Evidence Blocks - Non-Small Cell Lung Cancer Version 11.2024 NCCN Guidelines with Evidence, Lung Cancer Version 3.2025 NCCN Guidelines with Evidence Blocks - Testicular Cancer Version, High-Risk Assessment: Colorectal, Endometrial, and Gastric Version 3.2024 Lung Cancer
https://www.nccn.org/guidelines/recently-published-guidelinesWebinars for Patients
to view afterward. Upcoming Live Webinars Non-Small Cell Lung Cancer (NSCLC) - Friday, January 17, 2025, ) Small Cell Lung Cancer (2022) 3025 Chemical Road, Suite 100, , webinar, patient resources, breast cancer, lung cancer, recorded webinars, recorded patient webinar
https://www.nccn.org/patientresources/patient-resources/patient-webinarsGuidelines for Patients
Version: 2022 Non-Small Cell Lung Cancer - Early, -Small Cell Lung Cancer - Metastatic Version: 2024, Cell Lung Cancer Version: 2024 Soft, Lung Cancer Screening Version: 2023, patient help, breast cancer patient, breast cancer resources, prostate cancer resources, lung cancer
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsORP Grant History
lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in ovarian cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in small cell lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in early stage non-small cell lung cancer AVEO, of combination therapies with afatinib in lung cancer Bristol-Myers Squibb Company and ImClone, of carboplatin, pemetrexed, and bevaciumab, with or without atezolizumab, in lung cancer
https://www.nccn.org/education-research/nccn-oncology-research-program/orp-grant-historyCollaborators
AssociationAmerican Cancer Society, Inc.American Head & Neck Society (AHNS)American Lung AssociationAmerican Lung Cancer Screening Initiative (ALCSI)American Thyroid AssociationAnal Cancer, QuebecFORCE: Facing Our Risk of Cancer EmpoweredFoundation for Women's CancerFree ME from Lung, Liver InstituteGlobal Resource for Advancing Cancer EducationGo2 Foundation for Lung CancerGood, Breast Cancer Research FoundationInternational Association for the Study of Lung Cancer (IASLC
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/collaboratorsAsia
for the treatment of lung cancer for patients in Vietnam. Moving forward, the groups plan to address the top, Non-Small Cell Lung Cancer Version 3.2023 (English) Non-Small Cell Lung Cancer Version 3.2023
https://www.nccn.org/global/global-program/asia2023 Summit Report
• Kristen Santiago, LUNGevity • Lisa Schlager, FORCE
https://www.nccn.org/docs/default-source/oncology-policy-program/2023-summit-report.pdf?sfvrsn=9db11db7_2Clinical Trials
for AML Relapse after Allogenic Hematopoietic Cell Transplantation Lung Cancer Yasir Elamin, MD, Study of Osimertinib in Combination with Selumetinib in EGFR Inhibitor Naïve Advanced EGFR Mutant Lung
https://www.nccn.org/education-research/nccn-oncology-research-program/clinical-trialsTransparency Process
Lung Cancer Screening Panel Version: 1.2025 ( Lung Cancer Screening ) Date: 2024-06-18 Transparency Panel Disclosures/Attendance
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsPermission to Cite or Use NCCN Content
Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Lung Cancer Screening Management of Immunotherapy, Neuroendocrine and Adrenal Tumors Non-Small Cell Lung Cancer Occult Primary Older Adult Oncology, Detection Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Smoking Cessation Soft, Myeloproliferative Neoplasms Neuroendocrine and Adrenal Tumors Non-Small Cell Lung Cancer Occult, Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentResume Screening
Neuroendocrine and Adrenal Tumors Non-Small Cell Lung Cancer Occult Primary Ovarian Cancer, Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin, /Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric Lung Cancer Screening, Checkpoint Inhibitors Kidney Cancer Liver Cancer Lung Cancer Screening Mantle Cell Lymphoma Marginal, Nasopharyngeal Cancer Nausea and Vomiting Neuroendocrine Tumors Non-Small Cell Lung Cancer - Early
https://www.nccn.org/covid-19/resume-screeningHarmonized Guidelines
and Adrenal Tumors Version 1.2022 Non-Small Cell Lung Cancer Version 4.2024 Occult, Cell Lung Cancer Version 2.2024 Soft Tissue Sarcoma Version 2.2022 Testicular, Guidelines™ (Vietnam) - Guidelines for Treatment of Cancer by Type Non-Small Cell Lung Cancer Version 3.2023 (English) Non-Small Cell Lung Cancer Version 3.2023 (Vietnamese
https://www.nccn.org/global/what-we-do/harmonized-guidelinesGuidelines Panels
Lung Cancer Screening Panel, Panel Non-Small Cell Lung Cancer, Small Cell Lung Cancer Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsNCCN_Oncology_Research_Program_Brochure
of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center
https://www.nccn.org/docs/default-source/oncology-research-program-(orp)/nccn_oncology_research_program_brochure.pdf?sfvrsn=ebab0181_3Guidelines for Patients
Lung Cancer Screening Version: 2023, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Lung Cancer Version: 2024 Soft Tissue
https://www.nccn.org/guidelines/patients2021-State-Oncology-Society-Forum-Summary
Cancer Action Network, Cancer Support Community, LUNGevity, and NCCN. It included an overview
https://www.nccn.org/docs/default-source/business-policy/2021-state-oncology-society-forum-summary.pdf?sfvrsn=1a14acee_2